OneLegacy Partners with XVIVO and Perfusion Solution to Launch the First Ex Vivo Lung Perfusion (EVLP) Center in the Western U.S.

WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the completion of the world’s first donor kidney ...

WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the completion of the world’s first-in-human cases ...

New Modes Are Beginning to Gain Ground on Fed-batch Strategy The therapeutic success of highly efficacious complex biologicals that are almost exclusively produced in cell culture such as antibodies ...

New perfusion technologies and AI-driven controls are accelerating adoption across commercial biologics manufacturing.

FUJIFILM Biosciences, announced the commercial launch of BalanCD HEK293 Perfusion A. Designed to expand and augment the company’s portfolio of gene therapy application solutions, BalanCD HEK293 ...

27 April 2025, Boston—In places like Australia, where metropolitan areas are separated by an entire continent, donor hearts used to go unused simply because transplant teams couldn’t get the organ to ...

PLYMOUTH, Mich., Feb. 20, 2026 /PRNewswire/ -- Orrum Clinical Analytics today announced a strategic partnership with LivaNova USA Inc. to connect LivaNova's Essenz™ Perfusion System to the analytics ...

Fed-batch gives you one data point per sample pull. Perfusion demands continuous, real-time process intelligence, and process analytical technology (PAT) is the only way to deliver it. As ...

ANDOVER, Mass., Aug. 2, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...

FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.